Credit Suisse’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-7,292
Closed -$135K 4292
2016
Q2
$135K Buy
+7,292
New +$194K ﹤0.01% 4000
2016
Q1
Sell
-935
Closed -$34K 4341
2015
Q4
$34K Buy
935
+249
+36% +$10.8K ﹤0.01% 4157
2015
Q3
$22K Sell
686
-2,720
-80% -$153K ﹤0.01% 4223
2015
Q2
$236K Buy
3,406
+1,370
+67% +$94.5K ﹤0.01% 4144
2015
Q1
$153K Sell
2,036
-2,759
-58% -$217K ﹤0.01% 4149
2014
Q4
$398K Buy
4,795
+3,184
+198% +$258K ﹤0.01% 3867
2014
Q3
$131K Sell
1,611
-1,521
-49% -$130K ﹤0.01% 4261
2014
Q2
$281K Buy
3,132
+342
+12% +$30.4K ﹤0.01% 4156
2014
Q1
$330K Buy
+2,790
New +$271K ﹤0.01% 4024

Other funds holding ALIM

Credit Suisse's ALIM Position: Q3 2016 in Review

Credit Suisse sold out of Alimera Sciences (ALIM) in Q3 2016, closing a stake of 7,292 shares — an estimated $135K sold.

Credit Suisse first reported a position in ALIM in Q1 2014 and held it in 9 quarters. The position peaked at $398K in Q4 2014. 54 funds tracked by Wall St. Rank hold ALIM as of Q3 2016.

  • Credit Suisse reported no remaining Alimera Sciences position as of Q3 2016 after selling out during the quarter.
  • Credit Suisse sold 7,292 Alimera Sciences shares in Q3 2016, an estimated $135K.
  • Credit Suisse first reported a position in Alimera Sciences in Q1 2014 and held it in 9 quarters.
  • Credit Suisse's Alimera Sciences position peaked at $398K in Q4 2014.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.